Clincosm LogoSign in Get a demo

stage ii prostate adenocarcinoma

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage II Prostate Adenocarcinoma Trial in Worldwide (Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation

Active, not recruiting
  • Stage II Prostate Adenocarcinoma
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Stereotactic Body Radiation Therapy (SBRT)
  • Mobile, Alabama
  • +292 more
Jan 11, 2023

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Canada, Puerto

Active, not recruiting
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Mobile, Alabama
  • +313 more
Sep 7, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
Has Results
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Rockford, Johnson Creek, Madison (Radiation Therapy

Recruiting
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • Radiation Therapy Treatment Planning and Simulation
  • SBRT
  • Rockford, Illinois
  • +2 more
Mar 7, 2022

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
Has Results
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

Completed
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Antiandrogen Therapy
  • +3 more
  • Detroit, Michigan
  • +2 more
Oct 4, 2020

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial (Bicalutamide, Laboratory Biomarker Analysis,

Withdrawn
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • (no location specified)
Jan 17, 2019